Skip to main content
British Medical Journal logoLink to British Medical Journal
. 1969 Mar 15;1(5645):670.1–673. doi: 10.1136/bmj.1.5645.670

Adverse Effect of Topical Fluorinated Corticosteroids in Rosacea

Ian Sneddon
PMCID: PMC1982750  PMID: 4237682

Abstract

Fourteen patients suffering from rosacea treated by prolonged topical applications of fluorinated steroids showed adverse effects. Aggravation and extension of telangiectasia occurred in all, and in most cessation of the treatment was followed by severe rebound inflammatory oedema and acute pustular eruption. The telangiectasia cleared or was much improved within three months of cessation of the use of fluorinated steroids. Hydrocortisone did not produce the same effect, and hence it was used, together with oral tetracycline, for treatment.

Full text

PDF
670-1

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Grice K. Tinea of the hand and forearm. Betamethasone valerate atrophy. Proc R Soc Med. 1966 Mar;59(3):254–255. [PMC free article] [PubMed] [Google Scholar]
  2. Ive F. A., Marks R. Tinea incognito. Br Med J. 1968 Jul 20;3(5611):149–152. doi: 10.1136/bmj.3.5611.149. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Sneddon I. B. A clinical trial of tetracycline in rosacea. Br J Dermatol. 1966 Dec;78(12):649–652. doi: 10.1111/j.1365-2133.1966.tb12168.x. [DOI] [PubMed] [Google Scholar]
  4. Sneddon I. B. Varicose ulcers and use of topical corticosteroids. Br Med J. 1968 Mar 2;1(5591):579–580. doi: 10.1136/bmj.1.5591.579-c. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES